MERYX
Meryx is a biotechnology company that develops orally bio-available cancer drugs targeting receptor tyrosine kinases. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancers such as leukemia, lung cancer, and melanoma. It offers potent inhibitors of MerTK, such as MRX-2843, a clinical drug candidate; and MRX-6313, a backup candidate that inhibit growth and initiate anti-tumor immunity in a range of hematologic and solid malignancies. Meryx was founded in 2013 and is based in Chapel Hill, North Carolina.
MERYX
Industry:
Biotechnology Medical Medical Device
Founded:
2013-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Website Url:
http://www.meryxpharma.com
Total Employee:
1+
Status:
Active
Contact:
(919) 985-7821
Total Funding:
5.6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS DreamHost Hosting Dreamhost DNS Meteor
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.meryxpharma.com
- Host name: apache2-cabo.iad1-shared-b7-24.dreamhost.com
- IP address: 67.205.5.96
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
